| Carli Rhylander, | |
|
2009 Nottingham Dr, Bellevue, NE 68123-2046 | |
| (402) 681-2672 | |
| Not Available |
| Full Name | Carli Rhylander |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 2009 Nottingham Dr, Bellevue, Nebraska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760080345 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Carli Rhylander, 2009 Nottingham Dr, Bellevue, NE 68123-2046 Ph: (402) 681-2672 | Carli Rhylander, 2009 Nottingham Dr, Bellevue, NE 68123-2046 Ph: (402) 681-2672 |
News Archive
People in wealthier neighborhoods drink alcohol twice as frequently as people in poorer areas, suggests a new study from the University of Pittsburgh Graduate School of Public Health and the Prevention Research Center of the Pacific Institute for Research and Evaluation.
The Association for Chemoreception Sciences (AChemS), a US-based scientific organization, is holding its 32nd annual meeting. About 700 scientists are gathering to present new information on the role of smell and taste in disease, nutrition and social interactions in humans as well as animals. Smell and taste play essential roles in our daily lives. These chemical senses serve as important warning systems, alerting us to the presence of potentially harmful situations or substances, including gas leaks, smoke, and spoiled food.
QIAGEN N.V. has made an offer and entered into exclusive negotiations to purchase a 47% initial stake in Ipsogen S.A. and subsequently make a public offer to fully acquire a global leader in molecular profiling and personalized healthcare diagnostics for a broad range of hematological cancers.
Pfizer Inc. announced today that two Phase 3 studies of Sutent® (sunitinib malate) in advanced breast cancer did not meet their primary endpoints. The SUN 1064 Phase 3 study of sunitinib in combination with docetaxel for the first-line treatment of patients with advanced HER-2 negative breast cancer did not show a statistically significant improvement in progression-free survival compared with docetaxel alone.
› Verified 2 days ago
Katherine Kimmerling, LIMHP, LADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 730 Fort Crook Rd N, Bellevue, NE 68005 Phone: 402-292-9105 Fax: 402-292-0342 | |
Mrs. Alyson Nichole Carter, LIMHP, PLADC,CPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 608 W 29th Ave, Bellevue, NE 68005 Phone: 419-203-3620 | |
Veronica Villa, PLADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1103 Galvin Rd S Ste L 1/2, Bellevue, NE 68005 Phone: 402-213-1655 | |
Jessica Fuller, PLMHP Counselor Medicare: Medicare Enrolled Practice Location: 11515 S 39th St, Bellevue, NE 68123 Phone: 402-292-9105 Fax: 402-292-0342 | |
Nandi Nzingha Naomi Thomas, PLADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 112 E Mission Ave, Bellevue, NE 68005 Phone: 402-257-1122 | |
Catherine Jo Howard, LMHP LCSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 1309 Harlan Dr Ste 102, Bellevue, NE 68005 Phone: 402-850-0151 | |
Nina Wilson, LMHP Counselor Medicare: Not Enrolled in Medicare Practice Location: 1406 Fort Crook Rd S, 401, Bellevue, NE 68005 Phone: 402-661-9102 |